NVAX: Nilai perusahaan marang bathi resik Novavax Pharma

Novavax Pharma - logo grafis emiten NVAX

Exclusive patents and stringent FDA oversight create a high barrier to entry in the sector. The GURU.Markets portal provides this chart, where the P/E valuation ratio, the value of which -18.60 determines the current status of the parameter, helps assess the asset's value. Novavax, Inc. (NVAX) revenues are based on government vaccine procurement, while its development strategy relies on the creation of combined influenza medications.

NVAX - Pangali P/E Novavax ing rentang 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Novavax Corp (NVAX)

- rega lan prakiraan konsensus rega:
Rega saham novavax.com|NVAX - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Novavax, Inc.|NVAX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator nilai aset resik miturut neraca:
Aset Bersih saben Siji Saham Novavax|NVAX - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku novavax.com|NVAX - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Kabeh Utang marang Dana Pribadi Novavax, Inc.|NVAX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Novavax Pharma|NVAX - Utang perusahaan|Utang-utang marang aset resik Novavax, Inc.|NVAX - Utang jangka dawa perusahaan|Tanggungan utang jangka cendhak perusahaan Novavax|Likuiditas darurat novavax.com
- statistik bathi lan rasio pasar:
NVAX - Penghasilan resik|Bathi sing dikarepake Novavax, Inc.|NVAX - Pangali P/E|Pangali Forward P/E Novavax Inc|NVAX - Pangali rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Novavax, Inc.|NVAX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Novavax|NVAX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan novavax.com|NVAX - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Novavax, Inc.
Analisis komprehensif perusahaan:Novavax, Inc.
Barang unggulan Novavax Corp

Finding fundamental support for Novavax, Inc. (NVAX) requires analyzing the correlation between the stock price and the profits generated by Nuvaxovid vaccine sales and partnership payments. This calculated price-to-earnings multiple measures market expectations regarding future earnings, where excessive growth in values signals that the asset is overvalued, while abnormally low figures may indicate business stagnation and the risk of capital freeze.

Analisis perusahaan pesaing

Pangali P/E gilead.com|Koefisien rega marang bathi CDTX (Cidara Corp)|CVAC (CureVac NV) - Nilai perusahaan marang bathi resik|Valneva Pharma - Koefisien rega marang bathi|Vir Corp - Rasio rega marang bathi|SIGA Technologies, Inc. - Pangali P/E|Periode bali modal bisnis emergentbiosolutions.com EBS|Atea Pharmaceuticals, Inc. (AVIR) - Rasio rega marang bathi|Invivyd - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi ENTA|Pangali P/E Inovio Pharma|Rasio rega marang bathi HilleVax, Inc. (HLVX)|Periode bali modal bisnis kalaristx.com|Rasio rega marang bathi Dyadic International, Inc. DYAI|NNVC: Pangali rega marang bathi|TLPH - Rasio rega marang bathi|Kapitalisasi marang bathi Cocrystal Pharma Corp|TRAW (trawspharma.com) - Koefisien rega marang bathi|DWTX (Dogwood Therapeutics) - Rasio rega marang bathi|QLGN (Qualigen Therapeutics, Inc.) - Pangali P/E|Pangali P/E AlloVir Bio|Koefisien rega marang bathi VBIV (VBI Vaccines Inc.)|Rasio rega marang bathi VIRI (virios.com)|Pangali P/E VXRT (Vaxart)